DexCom, Inc.
DXCM
$66.33
$0.711.08%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.21% | 9.30% | 9.11% | 11.34% | 16.19% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.21% | 9.30% | 9.11% | 11.34% | 16.19% |
| Cost of Revenue | 22.17% | 20.94% | 19.04% | 19.60% | 23.23% |
| Gross Profit | 9.27% | 2.39% | 3.23% | 6.52% | 12.21% |
| SG&A Expenses | 2.77% | 2.41% | 5.65% | 8.47% | 6.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.39% | 11.07% | 11.59% | 13.50% | 14.82% |
| Operating Income | 23.84% | 0.84% | -2.92% | 0.38% | 24.06% |
| Income Before Tax | 28.92% | -2.83% | -6.12% | -0.20% | 24.52% |
| Income Tax Expenses | 277.65% | 51.86% | 40.62% | -21.37% | -71.37% |
| Earnings from Continuing Operations | 5.86% | -14.30% | -16.28% | 6.41% | 80.58% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.86% | -14.30% | -16.28% | 6.41% | 80.58% |
| EBIT | 23.84% | 0.84% | -2.92% | 0.38% | 24.06% |
| EBITDA | 21.62% | 4.12% | 1.10% | 4.34% | 24.32% |
| EPS Basic | 5.66% | -14.95% | -17.86% | 4.25% | 78.78% |
| Normalized Basic EPS | 28.95% | -3.48% | -7.86% | -2.20% | 23.06% |
| EPS Diluted | 7.71% | -11.97% | -14.00% | 8.69% | 83.50% |
| Normalized Diluted EPS | 31.28% | -0.12% | -3.31% | 2.51% | 28.19% |
| Average Basic Shares Outstanding | -0.18% | 0.51% | 1.78% | 1.95% | 1.38% |
| Average Diluted Shares Outstanding | -1.80% | -2.60% | -2.94% | -2.50% | -2.53% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |